http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-200980-A3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29c3aed20434a23dfcb9ac58acd603a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dbeab7c420445e258c1383878607491 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
filingDate | 2009-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df501c1f10be20836fa99292ed897897 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dae4629873bd980ab8787a133d2fb95 |
publicationDate | 2010-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CZ-200980-A3 |
titleOfInvention | A composition intended for buccal absorption of nicotine for smoking cessation |
abstract | The composition intended for buccal absorption of nicotine into the systemic circulation and distribution into the central nervous system for smoking cessation or substitution under unfavorable smoking conditions according to the invention comprises a solution of nicotine in the base form and / or its salt with organic acid at a concentration of 0.01 to. 8.00 wt. and a solution of acetylcysteine at a concentration of 0.1 to 40 wt. It contains 0.05 to 3.00 mg of nicotine per dose. |
priorityDate | 2009-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.